MIAMI UNIVERSITY 
OXFORD, OHIO 45056 
THE GRADUATE SCHOOL AND RESEARCH 
OFFICE OF THE DEAN 
TelepFione: (513) 529-4125 
November 5, 1982 
Mr. William J. Gartland, Jr. Ph.D. 
Director, Office of Recombinant DNA 
Acti vities 
National Institutes of Health 
Bethesda, Maryland 20205 
Dear Bill: 
We have now appointed our committee for 1982-1983 with one change in 
membership. The change is to add the University Safety Officer in place of 
Mr. Clevenger. I am enclosing Mr. Andrew Garci a - R i vera 1 s resume for your 
files and consideration. It is my understanding that this change should 
not cause problems but if it does we will get things changed back. 
In answer to your questions we found that the new guidelines helped us 
in regard to committee structure. With our low-key operation, nothing is 
taking a great deal of or inappropriate amounts of time. 
All of the experiments in progress to date are below PI containment 
but we have chosen to use PI rules for our safety. The IBC meets once or 
twice a year, depending on the work load, which is light. 
The committee refused to take on the responsibility of being a general 
biosafety committee. I think that they did not want the added respon- 
sibility and liability. I personally think that this choice was made 
because the NIH law and the University rules gave them a choice. We feel 
that the addition of a Safety Officer to the University staff will greatly 
improve our committee function. 
We extend thanks to you and your staff for your constant interest in 
us, the committee members. 
Sincerely, 
Kenneth G. Wilson 
Chair, Institutional 
Biosafety Committee 
KGW/eg 
[ 537 ] 
